ARE WE READY TO INDICATE MYELODYSPLASTIC SYNDROME PATIENTS TO HEMATOPOIETIC STEM CELL TRANSPLANTATION BASED ON THEIR GENETIC STATUS?

Authors

  • Mair Pedro de Souza
  • Fernanda Leite Souza Franceschi
  • Fernando Barroso Duarte
  • Diego Coutinho
  • Beatrice Araujo Duarte
  • Romelia Pinheiro Gonçalves Lemes
  • Vergilio Colturato

DOI:

https://doi.org/10.46765/2675-374X.2020v2n1p16-19

Abstract

Mielodysplastic syndrome and hematopoietic stem cell transplantation based on genetic status.

Downloads

Published

10/14/2020

How to Cite

de Souza, M. P., Franceschi, F. L. S., Duarte, F. B., Coutinho, D., Duarte, B. A., Lemes, R. P. G., & Colturato, V. (2020). ARE WE READY TO INDICATE MYELODYSPLASTIC SYNDROME PATIENTS TO HEMATOPOIETIC STEM CELL TRANSPLANTATION BASED ON THEIR GENETIC STATUS?. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 1(3), 16–19. https://doi.org/10.46765/2675-374X.2020v2n1p16-19

Issue

Vol. 1 No. 3 (2020): Journal of Bone Marrow Transplantation and Cellular Therapy

Section

Original article

License

Copyright (c) 2020 Mair Pedro de Souza, Fernanda Leite Souza Franceschi, Fernando Barroso Duarte, Diego Coutinho, Beatrice Araujo Duarte, Romelia Pinheiro Gonçalves Lemes, Vergilio Colturato

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.